CAR T-Cell Therapy in Hematological Malignancies

CAR T-Cell Therapy in Hematological Malignancies

Chimeric antigen receptor (CAR) T-cells (CAR T-cells) are a promising therapeutic approach in treating hematological malignancies. CAR T-cells represent engineered autologous T-cells, expressing a synthetic CAR, targeting tumor-associated antigens (TAAs) independent of major histocompatibility compl...

Full description

Bibliographic Details
Main Authors: Theresa Haslauer, Richard Greil, Nadja Zaborsky, Roland Geisberger
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
CAR T-cells
hematological malignancies
leukemia
lymphoma
Online Access:https://www.mdpi.com/1422-0067/22/16/8996

Internet

https://www.mdpi.com/1422-0067/22/16/8996

Similar Items